Halberd

Halberd Gross Margin

The Gross Margin of Halberd (HALB) as of Oct 11, 2026 is -20.72 %. In the previous year, Gross Margin was 48.44 % — a change of -142.78% (lower).

Gross Margin

-20.72 %

YoY

-142.78%

Last updated:

Gross Margin of Halberd is 2024 -20.72 % . Gross Margin of Halberd was 2023 48.44 % . It decreases by -142.78% lower compared to the previous year.

Halberd's gross margin stands at -20.7%, down from 100.0% several years earlier.

The Halberd Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2012
0.99 USD
Jan 1, 2013
0.99 USD
Jan 1, 2016
100.00 USD
Jan 1, 2017
100.00 USD
Jan 1, 2021
18.00 USD
Jan 1, 2022
97.33 USD
Jan 1, 2023
48.44 USD
Jan 1, 2024
-20.72 USD
The Halberd Gross Margin history
YEARGross MarginYoY
-20.72 %-142.78%
48.44 %-50.23%
97.33 %+440.64%
18.00 %-82.00%
100.00 %0.00%
100.00 %+9,963.52%
0.99 %-0.10%
0.99 %+8.63%
0.92 %+60.23%
0.57 %-100.91%
-62.79 %-7,016.11%
0.91 %—
Access this data via the Eulerpool API

Halberd Stock analysis

What does Halberd do? The Halberd Corp is an American company founded in 1987 and based in New York. It is a high-tech company focused on the development of medical technologies. Since its inception, the company has developed numerous innovative products and technologies that are used worldwide. A significant portion of Halberd Corp's business model focuses on providing medical products and solutions for various diseases. The main divisions of the company are biotechnology and pharmaceuticals, medical respiratory protection, medical technology, and the development of antibodies and diagnostics. Some of the most well-known products of Halberd Corp are the Medical Respiratory Masks, which were of great importance during the COVID-19 pandemic. These masks were developed and distributed worldwide by the company with innovative technology and the highest quality standards. The company has also developed various medical devices such as infusion pumps, blood pressure monitors, and various diagnostic devices that have been used by hospitals and care facilities. Another important business area of Halberd Corp is biotechnology and pharmaceuticals. In this field, the company specializes in developing new drugs and therapies for various diseases. The company has developed a range of proprietary medications that are used in the treatment of various diseases. Halberd Corp is also known for its development of antibodies and diagnostics and offers corresponding test kits. In recent years, Halberd Corp has formed numerous partnerships with other companies and institutions to bring its innovations to the market and market them. The company is also known for its successful joint ventures with other companies in the healthcare sector. Overall, Halberd Corp is an innovative company focused on medical technologies. With its presence in various areas of the healthcare industry, the company is able to develop new products and solutions that have the potential to improve and save lives. Halberd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Halberd stock

Gross Margin of Halberd is -20.72 % in 2024.

Gross Margin of Halberd changed from 48.44 % to -20.72 %, representing a -142.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Halberd since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Halberd with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — Halberd

All Key Metrics — Halberd